Alpha Cognition Inc. Derivative Liability
Alpha Cognition Inc. (ACOG) had Derivative Liability of $2.35 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2025-11-13
- 2025-09-30: Derivative Liability $2.35M.
- 2024-12-31: Derivative Liability $2.67M; Derivative Liability as first filed $2.05M.
| Period end | Derivative Liability | Derivative Liability as first filed |
|---|---|---|
| 2025-09-30 | $2.35M 10-Q · filed 2025-11-13 | |
| 2024-12-31 | $2.67M 10-Q · filed 2025-11-13 | $2.05M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |